NexImmune, Inc. (NEXI)
OTCMKTS
· Delayed Price · Currency is USD
0.272
+0.040 (17.24%)
Dec 19, 2024, 3:00 PM EST
NexImmune Market Cap
NexImmune has a market cap or net worth of $323.56 thousand as of December 20, 2024. Its market cap has decreased by -85.08% in one year.
Market Cap
323.56K
Enterprise Value
-2.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.27
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 323.56K, a decrease of -99.94%. That is a compound annual growth rate of -85.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2024 | 379.63K | -83.84% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 18.12B |
| Telix Pharmaceuticals Limited | 5.18B |
| Elekta AB (publ) | 2.11B |
| Ryman Healthcare Limited | 1.71B |
| Verano Holdings Corp. | 449.85M |
| Vireo Growth Inc. | 125.14M |
| Medexus Pharmaceuticals Inc. | 44.65M |